InvestorsHub Logo
Followers 8
Posts 249
Boards Moderated 0
Alias Born 10/10/2012

Re: Lemoncat post# 355473

Tuesday, 04/13/2021 10:11:53 PM

Tuesday, April 13, 2021 10:11:53 PM

Post# of 403742
We view it differently then. I see the B-UP arm as an indication that IPIX was okay with not getting a massive upfront payment. What I find massive value in is the cost savings at them fronting the cost for any research & trials. In the agreement all findings will be shared with IPIX which could potentially be used to support other indications of Bril. 10s of millions of dollars were saved with this deal. Don’t forget there’s a clause in there too that IPIX can yank the indication for B-UP if progress isn’t made. I also scratch any trials other than cancer or covid related off as hospitals around the would came to a halt.

Trust me if covid results are positive. Than pan coronavirus alone are multiple trials that will need to be tackled on top of the other indications we have planned.

We have enough on our plate right now. It’s now up to bril to flex its muscles.

Go IPIX.